Insilicogen and German QuiaGen to Establish and Operate 'Domestic Bio Data Center'
Bioinformatics specialist company Insilicogen Inc. announced on the 11th that it will jointly install and operate a domestic data center with global biotechnology company QIAGEN. QIAGEN is a German bio company that supplies DNA and RNA extraction kits and gene analysis software worldwide.
According to Insilicogen, QIAGEN's domestic data center installation will be the third in the world, following Denmark and the United States. The 'QCII' data center installed in Korea is a web-based software that curates large-scale bioinformatics databases to facilitate access to the field of precision medicine.
QCII is the first NGS interpretation platform to obtain approval under the European In Vitro Diagnostic Medical Device Regulation (CE-IVDR). It supports personalized treatment by clinically interpreting gene variants analyzed from NGS (Next-Generation Sequencing) data.
Hot Picks Today
"ByteDance Employee in His 20s Quits After 'Earning $30 Million from Stocks'... But Here's the Truth"
- "I Thought My Life Would Change After Getting Hired at SK Hynix, But After Starting Work, My Salary Was..." The Reason Behind the Disappointment
- "Quitting Delivery Was the Right Move" $30,000 Monthly Windfall... Young Americans Leave Jobs to Start Businesses
- "Manager Kim Is Disappearing"... KT Scales Down Workforce Aged 40 and Older
- Suspicious Achievements of Famous 'Beauty' Policewoman Revealed to Be Handed Over by Male Colleagues... Taiwan in Shock
An Insilicogen official explained, "QIAGEN has established the QCII data center domestically to enable clinical interpretation of NGS variant data in Korea while complying with domestic medical and data-related laws."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
